Depolarization and repolarization parameters on ECG predict recurrence after atrial fibrillation ablation in patients with hypertrophic cardiomyopathy
Introduction The outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from ablation and who are more likely to show treatment failure, especially in those with structural heart disease such as hypertrophic cardiomyopa...
Saved in:
Published in | Journal of cardiovascular electrophysiology Vol. 30; no. 11; pp. 2405 - 2413 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.11.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction
The outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from ablation and who are more likely to show treatment failure, especially in those with structural heart disease such as hypertrophic cardiomyopathy (HCM).
Methods and Results
We enrolled 120 HCM patients who underwent primary AF ablation (48 with persistent AF). Preprocedural QTc was measured and corrected using the Bazett's formula, and the distribution of fragmentation of the QRS complex (fQRS) was recorded. Arrhythmia recurrence was defined as any kind of documented atrial tachyarrhythmia of more than 30 seconds. Overall, arrhythmia recurrence occurred in 69 patients after 13.4 months’ follow‐up. fQRS was present in 71 (59.17%) patients and was most commonly (81.69%) observed in the inferior leads. QTc more than 448 ms could predict arrhythmia recurrence with a sensitivity of 68.1% and specificity of 68.6%. Patients with QTc more than 448 ms (hazard ratio [HR]: 1.982; 95% confidence interval [CI]: 1.155‐3.402; P = .013) or those with fQRS+ (HR: 1.922; 95% CI: 1.151‐3.210; P = .012) were at an increased risk of recurrence. A combination of fQRS+ and QTc more than 448 ms was superior to fQRS or QTc alone in predicting arrhythmia recurrence.
Conclusion
In patients with HCM undergoing AF ablation, QTc prolongation, specifically >448 ms, and presence of fQRS are independent risk factors for arrhythmia recurrence at follow‐up. The combination of these two parameters has greater predictive value and would help to identify patients who are at the highest risk of procedural failure. |
---|---|
AbstractList | The outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from ablation and who are more likely to show treatment failure, especially in those with structural heart disease such as hypertrophic cardiomyopathy (HCM).INTRODUCTIONThe outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from ablation and who are more likely to show treatment failure, especially in those with structural heart disease such as hypertrophic cardiomyopathy (HCM).We enrolled 120 HCM patients who underwent primary AF ablation (48 with persistent AF). Preprocedural QTc was measured and corrected using the Bazett's formula, and the distribution of fragmentation of the QRS complex (fQRS) was recorded. Arrhythmia recurrence was defined as any kind of documented atrial tachyarrhythmia of more than 30 seconds. Overall, arrhythmia recurrence occurred in 69 patients after 13.4 months' follow-up. fQRS was present in 71 (59.17%) patients and was most commonly (81.69%) observed in the inferior leads. QTc more than 448 ms could predict arrhythmia recurrence with a sensitivity of 68.1% and specificity of 68.6%. Patients with QTc more than 448 ms (hazard ratio [HR]: 1.982; 95% confidence interval [CI]: 1.155-3.402; P = .013) or those with fQRS+ (HR: 1.922; 95% CI: 1.151-3.210; P = .012) were at an increased risk of recurrence. A combination of fQRS+ and QTc more than 448 ms was superior to fQRS or QTc alone in predicting arrhythmia recurrence.METHODS AND RESULTSWe enrolled 120 HCM patients who underwent primary AF ablation (48 with persistent AF). Preprocedural QTc was measured and corrected using the Bazett's formula, and the distribution of fragmentation of the QRS complex (fQRS) was recorded. Arrhythmia recurrence was defined as any kind of documented atrial tachyarrhythmia of more than 30 seconds. Overall, arrhythmia recurrence occurred in 69 patients after 13.4 months' follow-up. fQRS was present in 71 (59.17%) patients and was most commonly (81.69%) observed in the inferior leads. QTc more than 448 ms could predict arrhythmia recurrence with a sensitivity of 68.1% and specificity of 68.6%. Patients with QTc more than 448 ms (hazard ratio [HR]: 1.982; 95% confidence interval [CI]: 1.155-3.402; P = .013) or those with fQRS+ (HR: 1.922; 95% CI: 1.151-3.210; P = .012) were at an increased risk of recurrence. A combination of fQRS+ and QTc more than 448 ms was superior to fQRS or QTc alone in predicting arrhythmia recurrence.In patients with HCM undergoing AF ablation, QTc prolongation, specifically >448 ms, and presence of fQRS are independent risk factors for arrhythmia recurrence at follow-up. The combination of these two parameters has greater predictive value and would help to identify patients who are at the highest risk of procedural failure.CONCLUSIONIn patients with HCM undergoing AF ablation, QTc prolongation, specifically >448 ms, and presence of fQRS are independent risk factors for arrhythmia recurrence at follow-up. The combination of these two parameters has greater predictive value and would help to identify patients who are at the highest risk of procedural failure. Introduction The outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from ablation and who are more likely to show treatment failure, especially in those with structural heart disease such as hypertrophic cardiomyopathy (HCM). Methods and Results We enrolled 120 HCM patients who underwent primary AF ablation (48 with persistent AF). Preprocedural QTc was measured and corrected using the Bazett's formula, and the distribution of fragmentation of the QRS complex (fQRS) was recorded. Arrhythmia recurrence was defined as any kind of documented atrial tachyarrhythmia of more than 30 seconds. Overall, arrhythmia recurrence occurred in 69 patients after 13.4 months’ follow‐up. fQRS was present in 71 (59.17%) patients and was most commonly (81.69%) observed in the inferior leads. QTc more than 448 ms could predict arrhythmia recurrence with a sensitivity of 68.1% and specificity of 68.6%. Patients with QTc more than 448 ms (hazard ratio [HR]: 1.982; 95% confidence interval [CI]: 1.155‐3.402; P = .013) or those with fQRS+ (HR: 1.922; 95% CI: 1.151‐3.210; P = .012) were at an increased risk of recurrence. A combination of fQRS+ and QTc more than 448 ms was superior to fQRS or QTc alone in predicting arrhythmia recurrence. Conclusion In patients with HCM undergoing AF ablation, QTc prolongation, specifically >448 ms, and presence of fQRS are independent risk factors for arrhythmia recurrence at follow‐up. The combination of these two parameters has greater predictive value and would help to identify patients who are at the highest risk of procedural failure. The outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from ablation and who are more likely to show treatment failure, especially in those with structural heart disease such as hypertrophic cardiomyopathy (HCM). We enrolled 120 HCM patients who underwent primary AF ablation (48 with persistent AF). Preprocedural QTc was measured and corrected using the Bazett's formula, and the distribution of fragmentation of the QRS complex (fQRS) was recorded. Arrhythmia recurrence was defined as any kind of documented atrial tachyarrhythmia of more than 30 seconds. Overall, arrhythmia recurrence occurred in 69 patients after 13.4 months' follow-up. fQRS was present in 71 (59.17%) patients and was most commonly (81.69%) observed in the inferior leads. QTc more than 448 ms could predict arrhythmia recurrence with a sensitivity of 68.1% and specificity of 68.6%. Patients with QTc more than 448 ms (hazard ratio [HR]: 1.982; 95% confidence interval [CI]: 1.155-3.402; P = .013) or those with fQRS+ (HR: 1.922; 95% CI: 1.151-3.210; P = .012) were at an increased risk of recurrence. A combination of fQRS+ and QTc more than 448 ms was superior to fQRS or QTc alone in predicting arrhythmia recurrence. In patients with HCM undergoing AF ablation, QTc prolongation, specifically >448 ms, and presence of fQRS are independent risk factors for arrhythmia recurrence at follow-up. The combination of these two parameters has greater predictive value and would help to identify patients who are at the highest risk of procedural failure. IntroductionThe outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from ablation and who are more likely to show treatment failure, especially in those with structural heart disease such as hypertrophic cardiomyopathy (HCM).Methods and ResultsWe enrolled 120 HCM patients who underwent primary AF ablation (48 with persistent AF). Preprocedural QTc was measured and corrected using the Bazett's formula, and the distribution of fragmentation of the QRS complex (fQRS) was recorded. Arrhythmia recurrence was defined as any kind of documented atrial tachyarrhythmia of more than 30 seconds. Overall, arrhythmia recurrence occurred in 69 patients after 13.4 months’ follow‐up. fQRS was present in 71 (59.17%) patients and was most commonly (81.69%) observed in the inferior leads. QTc more than 448 ms could predict arrhythmia recurrence with a sensitivity of 68.1% and specificity of 68.6%. Patients with QTc more than 448 ms (hazard ratio [HR]: 1.982; 95% confidence interval [CI]: 1.155‐3.402; P = .013) or those with fQRS+ (HR: 1.922; 95% CI: 1.151‐3.210; P = .012) were at an increased risk of recurrence. A combination of fQRS+ and QTc more than 448 ms was superior to fQRS or QTc alone in predicting arrhythmia recurrence.ConclusionIn patients with HCM undergoing AF ablation, QTc prolongation, specifically >448 ms, and presence of fQRS are independent risk factors for arrhythmia recurrence at follow‐up. The combination of these two parameters has greater predictive value and would help to identify patients who are at the highest risk of procedural failure. |
Author | Ma, Chang‐Sheng Ruan, Yan‐Fei Sun, Peng‐Yu Yu, Rong‐Hui Wen, Song‐Nan Wu, Kui Long, De‐Yong Li, Xin Bai, Rong Li, Song‐Nan Jiang, Chen‐Xi Du, Xin Tang, Ri‐Bo Liu, Nian Dong, Jian‐Zeng Hu, Rong Zhu, Hao‐Jie Sang, Cai‐Hua |
Author_xml | – sequence: 1 givenname: Song‐Nan surname: Wen fullname: Wen, Song‐Nan organization: Capital Medical University – sequence: 2 givenname: Hao‐Jie surname: Zhu fullname: Zhu, Hao‐Jie organization: Capital Medical University – sequence: 3 givenname: Peng‐Yu surname: Sun fullname: Sun, Peng‐Yu organization: Capital Medical University – sequence: 4 givenname: Kui surname: Wu fullname: Wu, Kui organization: Capital Medical University – sequence: 5 givenname: Nian orcidid: 0000-0002-3324-8606 surname: Liu fullname: Liu, Nian organization: Capital Medical University – sequence: 6 givenname: Yan‐Fei surname: Ruan fullname: Ruan, Yan‐Fei organization: Capital Medical University – sequence: 7 givenname: Rong orcidid: 0000-0002-3106-7318 surname: Bai fullname: Bai, Rong organization: Capital Medical University – sequence: 8 givenname: Ri‐Bo surname: Tang fullname: Tang, Ri‐Bo organization: Capital Medical University – sequence: 9 givenname: Rong‐Hui surname: Yu fullname: Yu, Rong‐Hui organization: Capital Medical University – sequence: 10 givenname: De‐Yong orcidid: 0000-0003-4604-5346 surname: Long fullname: Long, De‐Yong organization: Capital Medical University – sequence: 11 givenname: Cai‐Hua surname: Sang fullname: Sang, Cai‐Hua organization: Capital Medical University – sequence: 12 givenname: Chen‐Xi surname: Jiang fullname: Jiang, Chen‐Xi organization: Capital Medical University – sequence: 13 givenname: Xin surname: Li fullname: Li, Xin organization: Capital Medical University – sequence: 14 givenname: Song‐Nan surname: Li fullname: Li, Song‐Nan organization: Capital Medical University – sequence: 15 givenname: Rong surname: Hu fullname: Hu, Rong organization: Capital Medical University – sequence: 16 givenname: Xin surname: Du fullname: Du, Xin organization: Capital Medical University – sequence: 17 givenname: Jian‐Zeng orcidid: 0000-0001-7299-7805 surname: Dong fullname: Dong, Jian‐Zeng organization: Capital Medical University – sequence: 18 givenname: Chang‐Sheng orcidid: 0000-0001-6966-6239 surname: Ma fullname: Ma, Chang‐Sheng email: chshma@vip.sina.com organization: Capital Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31441155$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc9u1DAQxi1URP_AgRdAlrjAIa0ndpzdI1q2BVSJC5wtx5lovUriMHZULQ_C89btpgcqmMuMrd_3aTTfOTsZw4iMvQVxCbmu9g4vQYGsX7AzqJQoVqDrkzwLVRVyVctTdh7jXgiQWlSv2KkEpQCq6oz9-YxT6C353zb5MHI7tpz-_pos2QETUuT5td3c8Imw9S5l0M1EODrktssAt4m87XnnG_J9vzg2y-AfrJLHMUV-59OO7w4TUqIw7bzjzlLrw3AImdkdXrOXne0jvln6Bft5vf2x-VLcfr_5uvl0WzhZybooS620FViVjegapaRupVbooNYtqLWtoXVat67TTWMBZOuwU0rYbo1OlR3IC_bh6DtR-DVjTGbw0WHefcQwR1OWKwkgKl1m9P0zdB9mGvN2ppRiXWtY6SpT7xZqbgZszUR-sHQwTxfPwNURcBRiJOyM8-nxQIms7w0I85CpyZmax0yz4uMzxZPpv9jF_c73ePg_aL5ttkfFPQ49s40 |
CitedBy_id | crossref_primary_10_3390_jcm14030809 crossref_primary_10_1016_j_cdtm_2020_05_006 crossref_primary_10_1016_j_hjc_2022_05_002 crossref_primary_10_1016_j_cjca_2024_01_026 crossref_primary_10_3389_fcvm_2024_1483591 crossref_primary_10_1016_j_cpcardiol_2022_101524 |
Cites_doi | 10.1161/CIRCULATIONAHA.105.595892 10.1001/jama.2014.3 10.1016/j.eupc.2005.05.015 10.1016/S0008-6363(02)00258-4 10.1097/RLI.0000000000000326 10.1046/j.1540-8167.2004.03625.x 10.1016/j.jacc.2013.03.032 10.1016/j.jacc.2011.06.011 10.1016/j.jacc.2007.09.026 10.1016/S0735-1097(01)01727-2 10.1253/circj.CJ-14-0822 10.1093/europace/euv067 10.1111/j.1540-8167.2006.00621.x 10.1016/0735-1097(90)90180-W 10.1161/CIR.0b013e318223e2bd 10.1161/CIRCULATIONAHA.108.770917 10.1016/j.jacc.2012.03.076 10.1253/circj.CJ-14-1290 10.12669/pjms.304.5064 10.1016/j.joa.2016.10.005 10.1111/pace.13292 10.1093/europace/euq013 10.1111/jce.12629 |
ContentType | Journal Article |
Copyright | 2019 Wiley Periodicals, Inc. |
Copyright_xml | – notice: 2019 Wiley Periodicals, Inc. |
DBID | AAYXX CITATION NPM 7QP K9. 7X8 |
DOI | 10.1111/jce.14137 |
DatabaseName | CrossRef PubMed Calcium & Calcified Tissue Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Biology |
EISSN | 1540-8167 |
EndPage | 2413 |
ExternalDocumentID | 31441155 10_1111_jce_14137 JCE14137 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: National Key Research and Development Program of China funderid: 2016YFC0900901; 2016YFC1201703; 2016YFC1301002; 2017YFC0908803; 2018YFC1312501 – fundername: Natural ScienceFoundation of Beijing Municipality funderid: 7161003 – fundername: Excellent Talent of Beijing funderid: 2015000021469G195 – fundername: National Natural Science Foundation of China funderid: 2015000021469G195 – fundername: Beijing Municipal Science & Technology Commission funderid: Z181100001718105 – fundername: Capital Health Research and Development of Special funderid: 2016‐2‐2062 – fundername: Natural ScienceFoundation of Beijing Municipality grantid: 7161003 – fundername: Capital Health Research and Development of Special grantid: 2016-2-2062 – fundername: National Key Research and Development Program of China grantid: 2016YFC0900901 – fundername: Beijing Municipal Science & Technology Commission grantid: Z181100001718105 – fundername: National Key Research and Development Program of China grantid: 2016YFC1301002 – fundername: National Key Research and Development Program of China grantid: 2017YFC0908803 – fundername: National Key Research and Development Program of China grantid: 2018YFC1312501 – fundername: Excellent Talent of Beijing grantid: 2015000021469G195 – fundername: National Natural Science Foundation of China grantid: 2015000021469G195 – fundername: National Key Research and Development Program of China grantid: 2016YFC1201703 |
GroupedDBID | --- .3N .GA .GJ .Y3 04C 05W 0R~ 10A 1OB 1OC 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOJX ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMSDO BMXJE BPMNR BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F D-I DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EAS EBC EBD EBS ECF ECT ECV EIHBH EJD EMB EMK EMOBN ENC EPT ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 Q~Q R.K RIWAO ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K VVN W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQ9 WQJ WRC WUP WVDHM WXI WXSBR XG1 ZGI ZXP ZZTAW ~IA ~WT AAYXX ACDOS AEYWJ AGHNM AGQPQ AGYGG CITATION NPM 7QP AAMMB AEFGJ AGXDD AIDQK AIDYY K9. 7X8 |
ID | FETCH-LOGICAL-c3537-22646a0e52b0fb4436d364ec176d149a71dc66dcf6bba113dcef440af9ec42f13 |
IEDL.DBID | DR2 |
ISSN | 1045-3873 1540-8167 |
IngestDate | Thu Jul 10 23:21:41 EDT 2025 Fri Jul 25 20:03:05 EDT 2025 Wed Feb 19 02:31:32 EST 2025 Thu Apr 24 23:06:17 EDT 2025 Tue Jul 01 01:54:08 EDT 2025 Wed Jan 22 16:37:59 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | QTc interval atrial fibrillation catheter ablation hypertrophic cardiomyopathy fragmented QRS |
Language | English |
License | 2019 Wiley Periodicals, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3537-22646a0e52b0fb4436d364ec176d149a71dc66dcf6bba113dcef440af9ec42f13 |
Notes | Part of results of this study has been accepted for an abstract presentation in 2017 Annual Session of European Society of Cardiology (Barcelona, Spain). Disclosure ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-6966-6239 0000-0001-7299-7805 0000-0003-4604-5346 0000-0002-3106-7318 0000-0002-3324-8606 |
PMID | 31441155 |
PQID | 2309761865 |
PQPubID | 1086397 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_2283110562 proquest_journals_2309761865 pubmed_primary_31441155 crossref_citationtrail_10_1111_jce_14137 crossref_primary_10_1111_jce_14137 wiley_primary_10_1111_jce_14137_JCE14137 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | November 2019 2019-11-00 2019-Nov 20191101 |
PublicationDateYYYYMMDD | 2019-11-01 |
PublicationDate_xml | – month: 11 year: 2019 text: November 2019 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | Journal of cardiovascular electrophysiology |
PublicationTitleAlternate | J Cardiovasc Electrophysiol |
PublicationYear | 2019 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | e_1_2_7_1_11_1 e_1_2_7_1_12_1 e_1_2_7_1_13_1 Çetin M (e_1_2_7_1_10_1) 2012; 12 Patel SI (e_1_2_7_1_18_1) 2018; 7 e_1_2_7_1_5_1 e_1_2_7_1_6_1 e_1_2_7_1_7_1 e_1_2_7_1_8_1 e_1_2_7_1_25_1 e_1_2_7_1_2_1 e_1_2_7_1_26_1 e_1_2_7_1_3_1 e_1_2_7_1_4_1 e_1_2_7_1_21_1 e_1_2_7_1_22_1 e_1_2_7_1_23_1 e_1_2_7_1_24_1 e_1_2_7_1_9_1 e_1_2_7_1_20_1 e_1_2_7_1_19_1 e_1_2_7_1_14_1 e_1_2_7_1_15_1 e_1_2_7_1_16_1 e_1_2_7_1_17_1 |
References_xml | – ident: e_1_2_7_1_7_1 doi: 10.1161/CIRCULATIONAHA.105.595892 – ident: e_1_2_7_1_23_1 doi: 10.1001/jama.2014.3 – ident: e_1_2_7_1_5_1 doi: 10.1016/j.eupc.2005.05.015 – ident: e_1_2_7_1_26_1 doi: 10.1016/S0008-6363(02)00258-4 – ident: e_1_2_7_1_24_1 doi: 10.1097/RLI.0000000000000326 – volume: 12 start-page: 576 year: 2012 ident: e_1_2_7_1_10_1 article-title: Fragmented QRS may predict postoperative atrial fibrillation in patients undergoing isolated coronary artery bypass graft surgery publication-title: Anadolu Kardiyol Derg – ident: e_1_2_7_1_14_1 doi: 10.1046/j.1540-8167.2004.03625.x – volume: 7 start-page: 1 year: 2018 ident: e_1_2_7_1_18_1 article-title: QT prolongation and sudden cardiac death risk in hypertrophic cardiomyopathy publication-title: Acta Cardiol – ident: e_1_2_7_1_11_1 doi: 10.1016/j.jacc.2013.03.032 – ident: e_1_2_7_1_13_1 doi: 10.1016/j.jacc.2011.06.011 – ident: e_1_2_7_1_25_1 doi: 10.1016/j.jacc.2007.09.026 – ident: e_1_2_7_1_3_1 doi: 10.1016/S0735-1097(01)01727-2 – ident: e_1_2_7_1_20_1 doi: 10.1253/circj.CJ-14-0822 – ident: e_1_2_7_1_16_1 doi: 10.1093/europace/euv067 – ident: e_1_2_7_1_15_1 doi: 10.1111/j.1540-8167.2006.00621.x – ident: e_1_2_7_1_2_1 doi: 10.1016/0735-1097(90)90180-W – ident: e_1_2_7_1_4_1 doi: 10.1161/CIR.0b013e318223e2bd – ident: e_1_2_7_1_8_1 doi: 10.1161/CIRCULATIONAHA.108.770917 – ident: e_1_2_7_1_21_1 doi: 10.1016/j.jacc.2012.03.076 – ident: e_1_2_7_1_12_1 doi: 10.1253/circj.CJ-14-1290 – ident: e_1_2_7_1_19_1 doi: 10.12669/pjms.304.5064 – ident: e_1_2_7_1_22_1 doi: 10.1016/j.joa.2016.10.005 – ident: e_1_2_7_1_17_1 doi: 10.1111/pace.13292 – ident: e_1_2_7_1_6_1 doi: 10.1093/europace/euq013 – ident: e_1_2_7_1_9_1 doi: 10.1111/jce.12629 |
SSID | ssj0013605 |
Score | 2.3268507 |
Snippet | Introduction
The outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from... The outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from ablation and... IntroductionThe outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2405 |
SubjectTerms | Arrhythmia atrial fibrillation Cardiac arrhythmia Cardiomyopathy catheter ablation Coronary artery disease Depolarization EKG Electrocardiography Fibrillation fragmented QRS Health risk assessment Heart diseases hypertrophic cardiomyopathy QTc interval Risk factors Tachyarrhythmia |
Title | Depolarization and repolarization parameters on ECG predict recurrence after atrial fibrillation ablation in patients with hypertrophic cardiomyopathy |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjce.14137 https://www.ncbi.nlm.nih.gov/pubmed/31441155 https://www.proquest.com/docview/2309761865 https://www.proquest.com/docview/2283110562 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZWi0BceOzyKCwrgxDiklUcO04jTm23ZbXSckCstAekyJ7Y2hVtWqXpofwQfi9jxwmUh4S4Ock4D3km_sae-YaQ1wJ4BsLwSCSl22bMZKRBsmhYGoETFgyZL9p38UGeXYrzq_Rqj7zrcmFafoh-wc1Zhv9fOwNXev2zkYNBM2fcZZK7WC0HiD4mP3YQ2pxI9DZSxx_LA6uQj-Lpeu7ORb8BzF286iec2X3yuXvVNs7ky8mm0Sfw9RcWx__8lgfkXgCidNRqzkOyZ6oDcjiq0AlfbOkb6kND_Zr7Abk97lp3LsJe_CH5dorYHf3ikMhJVVXSeveU4xVfuHibNcWj6eQ9XdWuf4OC4ImhwFBfpZwqXz6EWpeBMJ-HO-rQuHG38vyva-oWjuk1es91Uy9X1zdAwYfULrZLV115-4hczqafJmdRqPIQAU95FrlMXqlikyY6tloILksuhQFUmxLdN5WxEqQswUqtFWO8BGOFiJXNDYjEMv6Y7FfLyjwlNGNJEttUKMZRouR5DAlIq20urFAiH5C33XgXECjQXSWOedG7QmAKPxAD8qoXXbW8H38SOuqUpgimvy7Qp0OIx4YyHZCX_WU0WrcToyqz3KAMgjrEXYg9B-RJq2z9U7hzcRHl4ct6lfn744vzydQ3nv276HNyFyFf3mZTHpH9pt6YFwirGn1Mbo3Gp-PZsbej72R2IPM |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lc9MwEN4pZXhceLQ8AgUEAx0u7liWLMcHDiVJSR_pgWlnejO2LE07JHbGcYYxP4RfwV_hP7GSHxAeM1x64KYkG1kj70rfSrvfArzkkgWSK-ZwLzXXjIFwEimo008Vxw1L9qkt2jc5FuNTfnDmn63B1zYXpuaH6A7cjGXY9doYuDmQ_tnKpUI7pyxoQioPVfUJHbbFm_0hvt1Xnrc3OhmMnaamgCOZzwLH5I2K2FW-l7g64ZyJlAmuJA4yRWchDmgqhUilFkkSU8pSqTTnbqxDJbmnKcN-r8BVU0HcMPUP33s_7izqLEz0b3zDWMsaHiMbN9QOdXX3-w3SriJku8Xt3YZv7eTUkS0fd5ZlsiM__8Ib-b_M3h241WBtslsbx11YU9kGbO5mcZnPKrJNbPSrvVbYgGtv29b1SRNusAlfhuieoOvf5KqSOEtJsfqVoU6fmZCiBcFPo8E7Mi_M_0sUlJb7SipiC7GT2FZIIdokWUynTY9J07gwXVmK2wUxZ-PkvJqroizy-fmFJNJGDc-q3BSQru7B6aVM231Yz_JMPQQSUM9ztc9jylAiZaErPSl0okOueczDHrxuFSySDcu7KTYyjTpvT6rIvvgevOhE5zW1yZ-EtlotjZrVbRGh24oolvaF34Pn3c-4LpnLpjhT-RJlELcitER43YMHtXZ3T2HGi0cgi4O1Ovr3x0cHg5FtPPp30WdwY3wyOYqO9o8PH8NNRLhhnTy6BetlsVRPEEWWyVNrvAQ-XLa-fwcE9n4s |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VIiouPFoeCwUMAsQlVRI7zubAoeyDPmiFEJV6C4kfasVuEmWzQuGH8Cf4K_woxs4DlofEpQduzmbWsZwZ-5t45huAp0zQUDBFHeZLc8wYcicV3HOGUjHcsMTQs0X7jo753gk7OA1O1-BrlwvT8EP0H9yMZdj12hh4IfXPRi4UmrlHwzai8lDVn9BfW7zcH-PLfeb708n70Z7TlhRwBA1o6Ji0UZ64KvBTV6eMUS4pZ0rgGCX6CknoScG5FJqnaeJ5VAqlGXMTHSnBfO1R7PcSXGbcjUydiPE7_8eRRZOEie5NYAhraUtjZMOGuqGubn6_IdpVgGx3uOl1-NbNTRPY8nFnWaU74vMvtJH_yeTdgGst0ia7jWnchDWVbcLWbpZU-bwmz4mNfbWHCptw5VXX2jhqgw224MsYnRN0_NtMVZJkkpSrPxni9LkJKFoQvJqMXpOiNP-vUFBY5iuhiC3DThJbH4Vok2Ixm7U9pm3j3HRlCW4XxHwZJ2d1ocqqzIuzc0GEjRme17kpH13fgpMLmbbbsJ7lmboLJPR839UBSzyKEpJGrvAF16mOmGYJiwbwotOvWLQc76bUyCzufT2hYvviB_CkFy0aYpM_CW13Shq3a9siRqcVMaw35MEAHve3cVUyR01JpvIlyiBqRWCJ4HoAdxrl7p9CjQ-PMBYHa1X074-PD0YT27j376KPYOPteBq_2T8-vA9XEd5GTeboNqxX5VI9QAhZpQ-t6RL4cNHq_h0CSXzb |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Depolarization+and+repolarization+parameters+on+ECG+predict+recurrence+after+atrial+fibrillation+ablation+in+patients+with+hypertrophic+cardiomyopathy&rft.jtitle=Journal+of+cardiovascular+electrophysiology&rft.au=Wen%2C+Song-Nan&rft.au=Zhu%2C+Hao-Jie&rft.au=Sun%2C+Peng-Yu&rft.au=Wu%2C+Kui&rft.date=2019-11-01&rft.eissn=1540-8167&rft.volume=30&rft.issue=11&rft.spage=2405&rft_id=info:doi/10.1111%2Fjce.14137&rft_id=info%3Apmid%2F31441155&rft.externalDocID=31441155 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1045-3873&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1045-3873&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1045-3873&client=summon |